Clinical studies recruiting near Bellaire

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
Phase 2/Phase 3 · Saint Hope Foundation, Inc. ( Site 1504) · Merck Sharp & Dohme LLC · NCT07266831 Evaluation of Pain Treatment After Total Knee Arthroplasty
Phase 4 · Legent Orthopedic and Spine Hospital · Vertex Pharmaceuticals Incorporated · NCT07538570 A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Pa
Phase 4 · Bellaire Dermatology Associates · Eli Lilly and Company · NCT06857942 A Study of Zasocitinib in Adults With Nonsegmental Vitiligo
Phase 2 · UT Health Science Center Houston · Takeda · NCT07108283 A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
Phase 3 · Saint Hope Foundation, Inc. ( Site 0015) · Merck Sharp & Dohme LLC · NCT07044297 A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1
Phase 2 · St. Hope Foundation · Gilead Sciences · NCT07645287 A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Phase N/A · Retina & Vitreous of Texas · Astellas Pharma Global Development, Inc. · NCT06779773 Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients
Phase 1/Phase 2 · RayTx Clinical Site · Ray Therapeutics, Inc. · NCT07439887 PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
Phase 4 · Novel Research LLC · Aurinia Pharmaceuticals Inc. · NCT07611214 A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Se
Phase 1/Phase 2 · Retina Consultants of Texas - Bellaire- Site Number : 840001 · Sanofi · NCT07215234 Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Phase 3 · JCCT - Juno Bellaire Site · Eli Lilly and Company · NCT07353931 A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atop
Phase 3 · The University of Texas Health Science Center at Houston · Organon and Co · NCT07265479 Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Preventio
Phase 3 · Retina Consultants of Texas, PA · Jaeb Center for Health Research · NCT05844982 Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
Phase 3 · Clinical Research Site · Axsome Therapeutics, Inc. · NCT07484217 A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Phase 3 · Akero Clinical Study Site · Akero Therapeutics, Inc · NCT06528314 A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary
Phase 3 · Retina Consultants of Texas (Bellaire) · Kodiak Sciences Inc · NCT06990399 Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIR
Phase 3 · Novel Research LLC · Novartis Pharmaceuticals · NCT06133972 A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Dep
Phase 2 · Houston Clinical Trials - Bellaire /ID# 277551 · AbbVie · NCT07276997 The OBSERVE Protocol
Phase N/A · Houston Center for Advanced Psychiatric Treatment · Yale University · NCT06725277 LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have C
Phase 3 · Pinnacle Clinical Research, LLC · Boehringer Ingelheim · NCT06632457 Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Maj
Phase 3 · Neurocrine Clinical Site · Neurocrine Biosciences · NCT06966401 A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Act
Phase 3 · Sl0044 50738 · UCB Biopharma SRL · NCT06617325 Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Phase 2 · Retina Consultants of Texas · ONL Therapeutics · NCT06659445 Evaluation of Non-Invasive Tests for Metabolic Liver Disease
Phase N/A · First Surgical Hospital · Foundation for the National Institutes of Health · NCT07122700 A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO
Phase 2 · Bellaire, Texas · EyeBiotech Ltd. · NCT07205887 AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Stud
Phase 2 · Artiva Investigational Site Bellaire · Artiva Biotherapeutics, Inc. · NCT06991114 A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in
Phase 3 · McGovern Medical School - UT Physicians Dermatology - Bellai · Sanofi · NCT06241118 A Study on TLC590 for Managing Postsurgical Pain
Phase 2 · First Surgical Hospital · TLC Biopharmaceuticals, Inc. · NCT06574269 Patient Priorities for Survivorship Care in Older Breast Cancer Survivors
Phase 2 · UT Physicians Center for Healthy Aging Bellaire · The University of Texas Health Science Center, Houston · NCT06478589 A Study of AAVB-039 in Participants With Stargardt Disease (STGD1)
Phase 1/Phase 2 · Retina Consultants of Texas · AAVantgarde Bio Srl · NCT07161544

Look up another city

Look up another condition